Gilead Sciences
GILD
2,291 hedge funds and large institutions have $141B invested in Gilead Sciences in 2026 Q2 according to their latest regulatory filings, with 155 funds opening new positions, 955 increasing their positions, 860 reducing their positions, and 166 closing their positions.
65% more call options, than puts
Call options by funds: $1.35B | Put options by funds: $816M
11% more repeat investments, than reductions
Existing positions increased: 955 | Existing positions reduced: 860
1.77% more ownership
Funds ownership: 87.77% → 89.54% (+1.8%)
7% less first-time investments, than exits
New positions opened: 155 | Existing positions closed: 166
2% less funds holding
Funds holding: 2,331 → 2,291 (-40)
7% less capital invested
Capital invested by funds: $152B → $141B (-$11.1B)
48% less funds holding in top 10
Funds holding in top 10: 33 → 17 (-16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$502M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$494M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$391M |
| 4 |
BlackRock
New York
|
+$373M |
| 5 |
D.E. Shaw & Co
New York
|
+$276M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.74B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.02B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$663M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$277M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$232M |
GILD Hedge Fund Activity: Q2 2026 in Review
2,291 of the 8,345 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2026, worth a combined $141B — down 7.3% from $152B a quarter earlier.
Sellers outnumbered buyers: 166 funds closed out of GILD and 155 opened new positions — a net loss of 11 holders — while 860 trimmed existing stakes and 955 added.
The largest buyer was SG Americas Securities, adding an estimated $502M. The largest seller was JP Morgan Chase, cutting an estimated $1.74B.
- 2,291 institutional investors held Gilead Sciences (GILD) as of Q2 2026, down from 2,331 in Q1 2026.
- Funds reported $141B of Gilead Sciences stock for Q2 2026, down 7.3% quarter-over-quarter.
- 155 funds opened new Gilead Sciences positions in Q2 2026 and 166 closed out, a net change of -11 holders.
- The largest Gilead Sciences buyer in Q2 2026 was SG Americas Securities, an estimated $502M added.
- The largest Gilead Sciences seller in Q2 2026 was JP Morgan Chase, an estimated $1.74B sold.
Based on aggregated 13F filings for Q2 2026.